Connecting you to content on EBSCOhost

Works by Hooper, Perry B.

Results: 4

1

Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 2, p. 591, doi. 10.1007/s13555-021-00665-y

By:

Au, Jeremiah H.;
Hooper, Perry B.;
Fitzgerald, Alison L.;
Somani, Ally-Khan

Publication type:

Article

2

Basal cell carcinoma has greater subclinical extension than squamous cell carcinoma: a cohort study.

Published in:

2024

By:

Rahman, Syed Minhaj;
Hooper, Perry B.;
Rohrer, Thomas E.

Publication type:

Letter

3

Keratoacanthoma centrifugum marginatum .

Published in:

Dermatology Online Journal, 2021, v. 27, n. 3, p. 1, doi. 10.5070/d3273052774

By:

Xiao, Honglin;
Hooper, Perry B.;
Umphress, Brandon A.;
Wolverton, Jay E.

Publication type:

Article

4

Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.

Published in:

Cancer Investigation, 2022, v. 40, n. 10, p. 911, doi. 10.1080/07357907.2022.2116454

By:

Hooper, Perry B.;
Farberg, Aaron S.;
Fitzgerald, Alison L.;
Siegel, Jennifer J.;
Rackley, Briana B.;
Prasai, Anesh;
Kurley, Sarah J.;
Goldberg, Matthew S.;
Litchman, Graham H.

Publication type:

Article